CPL - Chalmers Publication Library
| Utbildning | Forskning | Styrkeområden | Om Chalmers | In English In English Ej inloggad.

N-[2-(maleimido)ethyl]-3-(trimethylstannyl)benzamide, a molecule for radiohalogenation of proteins and peptides

Emma Aneheim ; Mark Foreman (Institutionen för kemi och kemiteknik, Kärnkemi) ; H. Jensen ; Sture Lindegren
Applied Radiation and Isotopes (0969-8043). Vol. 96 (2015), p. 1-5.
[Artikel, refereegranskad vetenskaplig]

In this work a new coupling reagent, N[2-(maleimido)ethyl]-3-(trimethylstannyl)benzamide, for radiohalogenation has been synthesized and characterized. The reagent is intended to either be attached to reduced disulfide bridges of proteins (making the halogenation site-specific) or to free terminal cysteine groups on peptides. The new reagent was also shown to be easily halogenated with inactive bromine and iodine as well as I-125 and At-211, indicating potential use within targeted radiotherapy.

Nyckelord: Halogenation, Astatine-211, Site specific antibody labelling, Peptide labelling, Targeted radiotherapy, Electrophilic aromatic substitution

Denna post skapades 2015-03-02. Senast ändrad 2015-10-27.
CPL Pubid: 213269


Läs direkt!

Länk till annan sajt (kan kräva inloggning)

Institutioner (Chalmers)

Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi, Avdelningen för radiofysik (GU)
Institutionen för kemi och kemiteknik, Kärnkemi



Chalmers infrastruktur